Search Results - "Valdenor, Czarlota"

Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial by Burgon, Trever, Casebeer, Linda, Aasen, Holly, Valdenor, Czarlota, Tamondong-Lachica, Diana, de Belen, Enrico, Paculdo, David, Peabody, John

“…Unwarranted variability in clinical practice is a challenging problem in practice today, leading to poor outcomes for patients and low-value care for…”
Get full text

Randomized clinical trial of a novel donor-derived cfDNA test to detect rejection in CPV-simulated renal transplant patients by Peabody, John, Billings, Paul, Valdenor, Czarlota, Demko, Zach, Moshkevich, Solomon, Tran, Mary, Paculdo, David

“…Purpose Five-year kidney graft loss currently stands at about 30%. We evaluate the clinical utility of a blood test measuring donor-derived cell-free DNA that…”
Get full text

Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease by Peabody, John W, Ganesan, Divya, Valdenor, Czarlota, Paculdo, David, Schrecker, Joshua, Westerfield, Christopher, Heltsley, Rebecca

“…Disentangling nonadherence (NA), drug-drug interactions (DDIs), and disease progression from each other is an important clinical challenge for providers caring…”
Get full text

Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice by Tran, Mary, Moshkevich, Solomon, Demko, Zach, Valdenor, Czarlota, Billings, Paul, Peabody, John, Paculdo, David

“…Background. The clinical utility of early detection and treatment of allograft rejection is well-established. Despite frequent testing called for by standard…”
Get full text

Establishing Clinical Utility for Diagnostic Tests Using a Randomized Controlled, Virtual Patient Trial Design by Peabody, John, Tran, Mary, Paculdo, David, Valdenor, Czarlota, Burgon, Trever, Jeter, Elaine

“…Demonstrating clinical utility for diagnostic tests and securing coverage and reimbursement requires high quality and, ideally, randomized controlled trial…”
Get full text

Standardising practice in cardiology: reducing clinical variation and cost at Ochsner Health System by Oravetz, Phil, White, Christopher J, Carmouche, David, Swan, Nicole, Donaldson, Josh, Ruhl, Russel, Valdenor, Czarlota, Paculdo, David, Tran, Mary, Peabody, John

“…ObjectiveLow quality and unwarranted clinical variation harm patients and increase unnecessary costs. Effective approaches to improve clinical and economic…”
Get full text

A nationwide program to improve clinical care quality in the Kyrgyz Republic by Peabody, John W, Oskombaeva, Klara, Shimarova, Memerian, Adylbaeva, Venera, Dzhorupbekova, Kanzaada, Sverdlova, Irina, Shukurova, Venera, Abdubalieva, Zhyldyz, Gagloeva, Natalya, Kudayarova, Ainura, Mukanbetovna, Aizhamal Asanbekova, Dzhumagazievna, Nurgul Shoonaeva, Vibornykh, Violetta, Zhorobekovna, Mimoza Satybaldieva, de Belen, Enrico, Paculdo, David, Tamondong-Lachica, Diana, Novinson, Daniel, Valdenor, Czarlota, Fritsche, Gyorgy

“…To assess baseline quality of care in the Kyrgyz Republic in 2019 and determine the effect of online simulated patients in changing doctors' practice in three…”
Get full text

Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug–Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians by Valdenor, Czarlota, Ganesan, Divya, Paculdo, David, Schrecker, Joshua, Heltsley, Rebecca, Westerfield, Christopher, Peabody, John W.

“…Background. Medication nonadherence in patients with chronic diseases is common, costly, and often underdiagnosed. In the United States, approximately 40–50%…”
Get full text

Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional Cardiologists by Valdenor, Czarlota, McCullough, Peter A., Paculdo, David, Acelajado, M. Czarina, Dahlen, Jeffrey R., Noiri, Eisei, Sugaya, Takeshi, Peabody, John

“…Contrast-induced acute kidney injury (CI-AKI) occurs in up to 10% of cardiac catheterizations and coronary interventions, resulting in increased morbidity,…”
Get full text

Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures by Peabody, John, Paculdo, David, Valdenor, Czarlota, McCullough, Peter A., Noiri, Eisei, Sugaya, Takeshi, Dahlen, Jeffrey R.

“…Introduction: Contrast-induced acute kidney injury (CI-AKI) is a major clinical complication of percutaneous cardiovascular procedures requiring iodinated…”
Get full text

Clinical Utility of Definitive Drug⁻Drug Interaction Testing in Primary Care by Peabody, John, Tran, Mary, Paculdo, David, Schrecker, Joshua, Valdenor, Czarlota, Jeter, Elaine

“…Drug⁻drug interactions (DDIs) are a leading cause of morbidity and mortality. New tools are needed to improve identification and treatment of DDIs. We…”
Get full text

N-005 PREDICTORS OF ADEQUATE CONTROL OF HYPERTENSION AMONG OUT-PATIENT CHRONIC KIDNEY DISEASE PATIENTS (PREACH-CKD) IN THE PHILIPPINE GENERAL HOSPITAL by Javier, Angelo Dave C, Acelajado-Valdenor, Czarlota, Acelajado-Onoya, Maria Czarina

“…BACKGROUNDHypertension is both a cause and a complication of chronic kidney disease(CKD). The National Kidney Foundation Kidney Disease Outcome and Quality…”
Get full text

Cushing’s syndrome in pregnancy by Holgado-Galicia, Margarita Victoria B, Magno, Jose Donato, Acelajado-Valdenor, Czarlota, Isip-Tan, Iris Thiele, Lim-Abrahan, Mary Anne

“…A 22-year-old G1P0 was admitted at 26 weeks gestation for preeclampsia, hyperglycaemia and cushingoid features. Elevated 24-h urine free cortisol (UFC) and…”
Get full text

Cushing’s syndrome in pregnancy by Holgado-Galicia, Margarita Victoria B, Magno, Jose Donato, Acelajado-Valdenor, Czarlota, Isip-Tan, Iris Thiele, Lim-Abrahan, Mary Anne

“…A 22-year-old G1P0 was admitted at 26 weeks gestation for preeclampsia, hyperglycaemia and cushingoid features. Elevated 24-h urine free cortisol (UFC) and…”
Get full text